BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10212120)

  • 1. Identification of highly selective inhibitors of collagenase-1 from combinatorial libraries of diketopiperazines.
    Szardenings AK; Antonenko V; Campbell DA; DeFrancisco N; Ida S; Shi L; Sharkov N; Tien D; Wang Y; Navre M
    J Med Chem; 1999 Apr; 42(8):1348-57. PubMed ID: 10212120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases.
    Szardenings AK; Harris D; Lam S; Shi L; Tien D; Wang Y; Patel DV; Navre M; Campbell DA
    J Med Chem; 1998 Jun; 41(13):2194-200. PubMed ID: 9632351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of potent, achiral matrix metalloproteinase inhibitors.
    Pikul S; McDow Dunham KL; Almstead NG; De B; Natchus MG; Anastasio MV; McPhail SJ; Snider CE; Taiwo YO; Rydel T; Dunaway CM; Gu F; Mieling GE
    J Med Chem; 1998 Sep; 41(19):3568-71. PubMed ID: 9733482
    [No Abstract]   [Full Text] [Related]  

  • 4. Structural basis for the highly selective inhibition of MMP-13.
    Engel CK; Pirard B; Schimanski S; Kirsch R; Habermann J; Klingler O; Schlotte V; Weithmann KU; Wendt KU
    Chem Biol; 2005 Feb; 12(2):181-9. PubMed ID: 15734645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel series of highly selective inhibitors of MMP-3.
    Whitlock GA; Dack KN; Dickinson RP; Lewis ML
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6750-3. PubMed ID: 18029177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potent and selective MMP-13 inhibitors.
    Wu J; Rush TS; Hotchandani R; Du X; Geck M; Collins E; Xu ZB; Skotnicki J; Levin JI; Lovering FE
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4105-9. PubMed ID: 16005220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a small library of diketopiperazines as potential inhibitors of calpain.
    Zeng Y; Li Q; Hanzlik RP; Aubé J
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3034-8. PubMed ID: 15896956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
    Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of a highly selective gelatinase inhibitor generates active metabolite.
    Lee M; Villegas-Estrada A; Celenza G; Boggess B; Toth M; Kreitinger G; Forbes C; Fridman R; Mobashery S; Chang M
    Chem Biol Drug Des; 2007 Nov; 70(5):371-82. PubMed ID: 17927722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrocyclic amino carboxylates as selective MMP-8 inhibitors.
    Cherney RJ; Wang L; Meyer DT; Xue CB; Wasserman ZR; Hardman KD; Welch PK; Covington MB; Copeland RA; Arner EC; DeGrado WF; Decicco CP
    J Med Chem; 1998 May; 41(11):1749-51. PubMed ID: 9599226
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.
    Matter H; Schwab W; Barbier D; Billen G; Haase B; Neises B; Schudok M; Thorwart W; Schreuder H; Brachvogel V; Lönze P; Weithmann KU
    J Med Chem; 1999 Jun; 42(11):1908-20. PubMed ID: 10354399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a multiple-enzyme/multiple-reagent assay system to quantify activity levels in samples containing mixtures of matrix metalloproteinases.
    Rasmussen FH; Yeung N; Kiefer L; Murphy G; Lopez-Otin C; Vitek MP; Moss ML
    Biochemistry; 2004 Mar; 43(11):2987-95. PubMed ID: 15023050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR analysis of some 5-amino-2-mercapto-1,3,4-thiadiazole based inhibitors of matrix metalloproteinases and bacterial collagenase.
    Jamloki A; Karthikeyan C; Hari Narayana Moorthy NS; Trivedi P
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3847-54. PubMed ID: 16682189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.
    Noe MC; Snow SL; Wolf-Gouveia LA; Mitchell PG; Lopresti-Morrow L; Reeves LM; Yocum SA; Liras JL; Vaughn M
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4727-30. PubMed ID: 15324896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).
    Kim SH; Pudzianowski AT; Leavitt KJ; Barbosa J; McDonnell PA; Metzler WJ; Rankin BM; Liu R; Vaccaro W; Pitts W
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1101-6. PubMed ID: 15686921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor targeting with a selective gelatinase inhibitor.
    Koivunen E; Arap W; Valtanen H; Rainisalo A; Medina OP; Heikkilä P; Kantor C; Gahmberg CG; Salo T; Konttinen YT; Sorsa T; Ruoslahti E; Pasqualini R
    Nat Biotechnol; 1999 Aug; 17(8):768-74. PubMed ID: 10429241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.
    Topai A; Breccia P; Minissi F; Padova A; Marini S; Cerbara I
    Bioorg Med Chem; 2012 Apr; 20(7):2323-37. PubMed ID: 22386984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.
    Vassiliou S; Mucha A; Cuniasse P; Georgiadis D; Lucet-Levannier K; Beau F; Kannan R; Murphy G; Knäuper V; Rio MC; Basset P; Yiotakis A; Dive V
    J Med Chem; 1999 Jul; 42(14):2610-20. PubMed ID: 10411481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of 3-OH-3-methylpipecolic hydroxamates: potent orally active inhibitors of aggrecanase and MMP-13.
    Noe MC; Natarajan V; Snow SL; Wolf-Gouveia LA; Mitchell PG; Lopresti-Morrow L; Reeves LM; Yocum SA; Otterness I; Bliven MA; Carty TJ; Barberia JT; Sweeney FJ; Liras JL; Vaughn M
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3385-8. PubMed ID: 15953722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors.
    Pinard E; Alberati D; Borroni E; Fischer H; Hainzl D; Jolidon S; Moreau JL; Narquizian R; Nettekoven M; Norcross RD; Stalder H; Thomas AW
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5134-9. PubMed ID: 18752953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.